E.N. Motylev

E.N. Motylev

Auto-generated profile, based on publicly available information

E.N. Motylev

Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
KMKsenia Maslenkina
Ksenia Maslenkina
EME.N. Motylev
E.N. Motylev
MGM.YU. Guschin
M.YU. Guschin
RVR.A. Vandysheva
R.A. Vandysheva
LMLiudmila Mikhaleva
Liudmila Mikhaleva
BACKGROUND Eosinophilic esophagitis (EoE) is an immune-mediated disease, manifested by dysphagia and characterized by intraepithelial infiltration: more than 15 eosinophils per field of view at x400 magnification, and requiring differential diagnosis with reflux esophagitis (RE). OBJECTIVE To access the implication of EoE histologic scoring system (EoEHSS) for differential diagnosis of EoE and RE and to characterize features of immune response in these diseases. MATERIAL AND METHODS 38 patients with EoE and 38 patients with RE were enrolled in the study. All the patients had esophagogastroduodenoscopy with biopsy. Biopsy specimens were stained with H&E and combined PAS/Alcian blue staining. Immunohistochemical evaluation was conducted with antibodies to CD3, CD4, CD8, CD20, CD56 and CD68. RESULTS Grade score of EoEHSS in EoE was 2.4 times more than in RE (p<0.05). Stage score in EoE was 2.75 more than in RE (p<0.05). Intraepithelial count of CD3+ T-lymphocytes comprised 87 (76—95.5) in high-power view in EoE and 45 (38.5—48.5) in high-power view in RE. Intraepithelial count of CD4+ T-lymphocytes was 35 (28—41.5) in high-power view in EoE and 19 (16.5— 22.5) in high-power view in RE. Intraepithelial count of CD8+ T-lymphocytes comprised 59 (50.5—67.5) in high-power field in EoE and 27 (24—28.5) in high-power field in RE. CONCLUSION The use of the EoEHSS histological rating scale for eosinophilic esophagitis is effective in the differential diagnosis of EoE and EC. Predominant cells in intraepithelial infiltrate are CD3+ T-lymphocytes both in EoE and RE, CD8+ cells prevail over CD4+ cells. In EoE intraepithelial count of CD3+ T-lymphocytes is 1.93 times more, count of intraepithelial CD4+ lymphocytes is 1.84 times more and count of CD8+ lymphocytes is 2.19 times more than in RE.

1 January 2023 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
EME.N. Motylev
E.N. Motylev
MGMikhail Yurevich Gushchin
Mikhail Yurevich Gushchin
VKV.O. Kaibysheva Kaibysheva
V.O. Kaibysheva Kaibysheva
GKG.Y. Kudryavtsev
G.Y. Kudryavtsev
Eosinophilic esophagitis (EoE) is an immune-mediated disease that presents with dysphagia and esophageal bolus obstruction and is characterized by predominant intraepithelial eosinophilic infiltration at histology. The aim of our literature review was to delineate clinical and morphological EoE features in terms of differential diagnosis with other esophageal diseases, i.e., gastroesophageal reflux disease (GERD), inflammatory bowel diseases (IBDs), autoimmune diseases, and rare esophageal disorders. Clinical features of dysphagia and esophageal bolus obstruction and endoscopic criteria (according to EREFS) are typical of EoE. Nevertheless, eosinophilia of the esophageal mucosa is not a specific marker of mucosal injury and is not sufficient for EoE diagnosis. Therefore, eosinophilic esophagitis histological scoring system (EoEHSS) was developed. It involves assessment of intraepithelial eosinophilic infiltration, basal zone hyperplasia, eosinophilic abscesses, eosinophil surface layering, dilated intercellular spaces, surface epithelial alteration, dyskeratotic epithelial cells, and lamina propria fibrosis. Complex clinical, endoscopic, and histological evaluation allows accurate diagnosis of EoE and other causal factors of esophageal eosinophilia. Keywords: eosinophilic esophagitis, esophageal eosinophilia, gastroesophageal reflux disease, celiac disease, inflammatory bowel diseases, achalasia, atopy

1 December 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
AMAlexander Mikhalev
Alexander Mikhalev
VKValeria Kaibysheva
Valeria Kaibysheva
DADmitrii Atiakshin
Dmitrii Atiakshin
MTMarkus Tiemann
Markus Tiemann
Eosinophilic esophagitis (EoE) is an immune-mediated disease that manifests with dysphagia and is characterized by the predominantly eosinophilic infiltration of the esophageal mucosa. Several instruments have been developed to assess the symptoms of EoE: the Daily Symptom Questionnaire (DSQ), EoE Activity Index (EEsAI), Pediatric EoE Symptom Severity (PEESSv2), etc. The use of the EREFS is a gold standard for endoscopic diagnosis. The EoE histologic scoring system (EoEHSS) was elaborated for the assessment of histological features in EoE. However, the remission criteria are not clearly defined and vary greatly in different studies. Gastroenterologists establish the severity of EoE mainly based on endoscopic findings. At the same time, EoE requires a multidisciplinary approach. The recently developed Index of Severity of Eosinophilic Esophagitis (I-SEE) that is built on symptoms, endoscopic findings, and histological features is promising.

1 January 2022 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
AKA.I. Khripun
A.I. Khripun
APA.D. Pryamikov
A.D. Pryamikov
AMA.B. Mironkov
A.B. Mironkov
MAM.V. Abashin
M.V. Abashin
ISI.V. Sazhin
I.V. Sazhin
EME.N. Motylev
E.N. Motylev
Представлен клинический случай эндоваскулярного лечения острой тромбоэмболической окклюзии верхней брыжеечной артерии у 75-летней пациентки, послеоперационный период у которой осложнился массивным реперфузионным и транслокационным синдромом. Компьютерная томография (КТ) органов брюшной полости с внутривенным контрастированием, выполненная через 12 ч после успешной аспирационной тромбэктомии из верхней брыжеечной артерии, продемонстрировала КТ-признаки необратимого повреждения кишечника: газ в венах печени, в стенке кишечника и венах его брыжейки, резкое истончение стенки кишечника. Кроме того, по данным КТ выявлен такой крайне редкий КТ-признак тяжелой острой мезентериальной ишемии, как газ в просвете верхней брыжеечной артерии и чревном стволе. Описание свободного газа в чревном стволе при остром нарушении мезентериального кровообращения в доступной нам литературе не встретилось.

1 January 2026 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
KMKsenia Maslenkina
Ksenia Maslenkina
LMLiudmila Mikhaleva
Liudmila Mikhaleva
MNM.S. Naumenko
M.S. Naumenko
EME.N. Motylev
E.N. Motylev
ABA.E. Birukov
A.E. Birukov
MGMikhail Yurevich Gushchin
Mikhail Yurevich Gushchin
Introduction. The incidence of gastroesophageal reflux disease, Barrett’s esophagus, and esophageal adenocarcinoma is rising. Eosinophilic esophagitis is the second most common non-neoplastic esophageal disease. The study aimed to evaluate the nosological spectrum of esophageal pathology in a multidisciplinary hospital based on esophageal biopsy specimens in the pathology department. Materials and methods. The study included 622 patients who underwent esophagogastroduodenoscopy with biopsy. Biopsy specimens were fixed in 10% neutral buffered formalin and routinely stained with haematoxylin and eosin, combined PAS/Alcian blue, and Mallory stain. Histopathological assessment of biopsies in patients with eosinophilic esophagitis was performed using the EoEHSS. Results. Non-neoplastic esophageal diseases were detected in 325 patients (52.25%), precancerous diseases, in 118 patients (18.97%); benign neoplasms, in 120 patients (19.29%); and malignant tumors, in 59 patients (9.49%). Among patients with esophagitis, chronic nonspecific and reflux esophagitis accounted for 65.93% of cases, while eosinophilic esophagitis was diagnosed in 28.57%. Complications of gastroesophageal reflux disease were distributed as follows: Barrett’s esophagus was observed in 50.22% of patients; columnar-lined esophagus with gastric-type metaplasia, in 39.21%; esophageal ulcer, in 9.25%; and esophageal stricture, in 1.32%. The rate of dysplasia in Barrett’s esophagus was 21.93%, whereas in gastric type metaplasia of distal esophagus, 4.49% (p<0.05). Thus, dysplasia in Barrett’s esophagus was diagnosed 4.88 times more often than in gastric-type metaplasia of the distal esophagus. Malignant neoplasms were detected in 59 patients (32.96% of all esophageal tumors). Conclusion. Among non-neoplastic esophageal diseases, eosinophilic esophagitis was in 11.74% of cases. Complications of gastroesophageal reflux disease predominated among non-neoplastic esophageal diseases (51.24%). During histological examination, particular attention should be paid to the presence of dysplastic changes. Keywords: esophageal diseases, eosinophilic esophagitis, gastroesophageal reflux disease, Barrett’s esophagus, esophageal cance

16 April 2026 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
EME.N. Motylev
E.N. Motylev
LMLiudmila Mikhaleva
Liudmila Mikhaleva
KMKsenia Maslenkina
Ksenia Maslenkina
AMA.I. Mikhalev
A.I. Mikhalev
MGMikhail Yurevich Gushchin
Mikhail Yurevich Gushchin
VKV.O. Kaybysheva
V.O. Kaybysheva
Eosinophilic esophagitis (EoE) is characterized by predominant eosinophilic infiltration of esophageal mucosa, >15 eosinophils in a high power field (HPF). Proton pomp inhibitors (PPI) are medications of choice to start therapy of EoE. Objective. To perform histological and morphometric analysis of biopsy pieces of esophageal mucosa before and after treatment with PPI. Material and methods. Of the 84 patients newly diagnosed with EoE, 30 were in the PPI therapy group. Patients underwent esophagogastroduodenoscopy with biopsy for initial diagnosis and follow-up evaluation. Biopsy specimens were stained with hematoxylin and eosin, combined PAS/Alcian blue staining and Mallory staining to detect fibrosis. Morphometric analysis was performed using the Eosinophilic Esophagitis Histologic Scoring System (EoEHSS) for initial diagnosis and Eosinophilic Esophagitis Histology Remission Score (EoEHRS) to assess the onset of remission. Results. In initial biopsies peak eosinophil count comprised 46 (25—89) eosinophils HPF, rates of basal zone hyperplasia and dilated intercellular spaces were both 100%, followed by lamina propria fibrosis (98.04%), surface epithelial alteration (77.38%), eosinophilic abscesses (57.14%), eosinophil surface layering (28.57%) and dyskeratosis (21.43%). Using EoEHSS, the total score for the grade was 12 (8—13.75) and the total score for the stage was 10 (8—12). Peak eosinophil count after the treatment alleviated in all the patients (4 (1—12) eosinophils HPF, p<0.05). The severity and the extent of other parameters has significantly decreased. Using EoEHSS, the total score for the grade was 4 [3—8] and the total score for the stage was 4 (3—7), p<0.05. Conclusion. Not only peak eosinophil count, but structural changes of esophageal mucosa should be taken into account while evaluating biopsies for initial diagnostic and to analyze the treatment response. EoEHRS remission criteria were reached in 40% patients on PPI therapy.